“Advancements in Multi-Strain, High-Potency Microbial Formulations”
- A significant and accelerating trend in the global direct-fed microbials market is the development of multi-strain, high-potency blends designed to enhance animal health, productivity, and gut performance across livestock species. These innovative formulations are tailored to improve feed efficiency, immunity, and overall animal well-being
- `For instance, Chr. Hansen Holding A/S expanded its microbial product portfolio in 2024 through the acquisition of UAS Laboratories, significantly enhancing its capabilities in high-potency, multi-species probiotics aimed at improving gut health and performance
- Technological innovations are enabling more targeted microbial combinations that can withstand harsh gastrointestinal environments, optimize nutrient absorption, and deliver consistent benefits across diverse production systems. Companies are investing in strain-specific research to enhance the efficacy of probiotics under different environmental and dietary conditions
- The increased use of advanced encapsulation techniques further boosts product stability and delivery, ensuring the viability of beneficial microbes in animal feed. This supports broader adoption of DFMs, particularly in regions facing regulatory restrictions on antibiotic growth promoters
- Key industry players such as Lallemand Inc. and BASF SE are at the forefront of developing next-generation DFMs that address specific challenges such as heat stress, pathogen control, and gut microbiome optimization
- The demand for scientifically backed, high-performance DFMs is growing rapidly across poultry, ruminants, swine, and aquaculture sectors, as producers increasingly seek sustainable, antibiotic-free solutions to improve animal health and productivity
